Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Carrier

Showing results (111-120 of 421) with videos related to

Pageof 43
Sort By:
Thrombosis Research|February 6, 2022
Safety and efficacy of apixaban thromboprophylaxis in ambulatory cancer patients according to renal function: A subgroup analysis of the AVERT trialTzu-Fei Wang, Ranjeeta Mallick, Marc Carrier, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 13, 2009
Practical application of the 10-mg warfarin initiation nomogramPhilip S Wells, Grégoire Le Gal, Sarah Tierney, et al.
Presse Medicale (Paris, France : 1983)|August 25, 2024
Preventative and curative treatment of venous thromboembolic disease in cancer patientsMarc Carrier, Laurent Bertoletti, Philippe Girard, et al.
Journal of Thrombosis and Haemostasis : JTH|February 3, 2024
Importance of early career professionals in the SSC of the ISTHKathleen Freson, Marc Carrier, Cary Clark, et al.
Hepatobiliary Surgery and Nutrition|December 13, 2024
"To bleed or to clot, that is the question"-the benefit of a procedure-specific risk tool to guide perioperative anticoagulationVictoria Ivankovic, Megan Delisle, Abdelrahman Noureldin, et al.
Minerva Medica|April 9, 2021
Treatment of portal vein thrombosis: an updated narrative reviewLucia M Caiano, Nicoletta Riva, Marc Carrier, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 1, 2025
Efficacy and safety of extended duration postoperative thromboprophylaxis with low molecular weight heparin among subgroups of patients undergoing surgical resection of colorectal cancer: A post-hoc analysis of the PERIOP-01 trialLaura Girardi, Ranjeeta Mallick, Tzu-Fei Wang, et al.
Thrombosis Research|June 10, 2023
Incidence of recurrent venous thromboembolism and bleeding complications in patients with cancer and isolated distal deep vein thrombosisCameron Brown, Willem Brandt, Tzu-Fei Wang, et al.
Annals of Internal Medicine|May 5, 2010
Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolismMarc Carrier, Grégoire Le Gal, Philip S Wells, et al.
Journal of Thrombosis and Thrombolysis|October 20, 2020
Thromboprophylaxis for patients with newly diagnosed vs. recurrent cancers: a post-hoc analysis of the avert trialJames Zhang, Marina Atalla, Ranjeeta Mallick, et al.
Pageof 43

Showing results (111-120 of 421) with videos related to

Sort By:
Pageof 43
Thrombosis Research|February 6, 2022
Safety and efficacy of apixaban thromboprophylaxis in ambulatory cancer patients according to renal function: A subgroup analysis of the AVERT trialTzu-Fei Wang, Ranjeeta Mallick, Marc Carrier, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 13, 2009
Practical application of the 10-mg warfarin initiation nomogramPhilip S Wells, Grégoire Le Gal, Sarah Tierney, et al.
Presse Medicale (Paris, France : 1983)|August 25, 2024
Preventative and curative treatment of venous thromboembolic disease in cancer patientsMarc Carrier, Laurent Bertoletti, Philippe Girard, et al.
Journal of Thrombosis and Haemostasis : JTH|February 3, 2024
Importance of early career professionals in the SSC of the ISTHKathleen Freson, Marc Carrier, Cary Clark, et al.
Hepatobiliary Surgery and Nutrition|December 13, 2024
"To bleed or to clot, that is the question"-the benefit of a procedure-specific risk tool to guide perioperative anticoagulationVictoria Ivankovic, Megan Delisle, Abdelrahman Noureldin, et al.
Minerva Medica|April 9, 2021
Treatment of portal vein thrombosis: an updated narrative reviewLucia M Caiano, Nicoletta Riva, Marc Carrier, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 1, 2025
Efficacy and safety of extended duration postoperative thromboprophylaxis with low molecular weight heparin among subgroups of patients undergoing surgical resection of colorectal cancer: A post-hoc analysis of the PERIOP-01 trialLaura Girardi, Ranjeeta Mallick, Tzu-Fei Wang, et al.
Thrombosis Research|June 10, 2023
Incidence of recurrent venous thromboembolism and bleeding complications in patients with cancer and isolated distal deep vein thrombosisCameron Brown, Willem Brandt, Tzu-Fei Wang, et al.
Annals of Internal Medicine|May 5, 2010
Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolismMarc Carrier, Grégoire Le Gal, Philip S Wells, et al.
Journal of Thrombosis and Thrombolysis|October 20, 2020
Thromboprophylaxis for patients with newly diagnosed vs. recurrent cancers: a post-hoc analysis of the avert trialJames Zhang, Marina Atalla, Ranjeeta Mallick, et al.
Pageof 43